bupranolol has been researched along with isosorbide-5-mononitrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Krepp, HP | 1 |
1 trial(s) available for bupranolol and isosorbide-5-mononitrate
| Article | Year |
|---|---|
Evaluation of the antianginal and anti-ischemic efficacy of slow-release isosorbide-5-mononitrate capsules, bupranolol and their combination, in patients with chronic stable angina pectoris.
Topics: Aged; Angina Pectoris; Bupranolol; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged | 1991 |
1 other study(ies) available for bupranolol and isosorbide-5-mononitrate
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |